Sign inJoin waitlistJoin the waitlist

Azka Ali

Physician · Cleveland Clinic

Credentials: · · · · · ·

History

Cleveland Clinic
2022–Present

Hematology and Medical Oncology
University of Florida
2019–2022
Internal Medicine
University of Florida
2016–2019
Med Univ of South Carolina Coll of Med
2011–2015
University of South Carolina
2007–2011

Research

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint…
Cancer Medicine · 2019 · 56 citations
The COP9 signalosome controls jasmonic acid synthesis and plant responses to herbivory and pathogens
The Plant Journal · 2011 · 53 citations
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer
Frontiers in Oncology · 2020 · 40 citations

LD
Long Dang
9 papers
William Skelton
8 papers · 8 as a resident
ND
Nam Dang
6 papers
Rohit Bishnoi
6 papers
Thomas George
4 papers
KW
Karen Daily Weinstein
3 papers
Ayoola Awosika
2 papers
Brian Ramnaraign
2 papers
CA
Carmen Allegra
2 papers
JW
James Wynne
2 papers
JC
Jason Chertoff
2 papers
NB
Neeka Brar
2 papers · 2 as a resident

Clinical trials

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Site PI · Recruiting · Phase 1
NiKang Therapeutics, Inc.
2025–2027
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Site PI · Recruiting · Phase 3
BriaCell Therapeutics Corporation
2023–2028